Jozef Madzo to Disease-Free Survival
This is a "connection" page, showing publications Jozef Madzo has written about Disease-Free Survival.
Connection Strength
0.058
-
Slower molecular response to treatment predicts poor outcome in patients with TEL/AML1 positive acute lymphoblastic leukemia: prospective real-time quantitative reverse transcriptase-polymerase chain reaction study. Cancer. 2003 Jan 01; 97(1):105-13.
Score: 0.045
-
Myeloid antigens in childhood lymphoblastic leukemia: clinical data point to regulation of CD66c distinct from other myeloid antigens. BMC Cancer. 2005 Apr 12; 5:38.
Score: 0.013